VRTX
NASDAQStockVertex Pharmaceuticals Incorporated
$479.41-13.10 (-2.66%)
52-Week Range
$366.54
$513.76
Key Stats
Market Cap
121.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.32
Volume
940.1K
Avg Volume
1.4M
Performance
1M
+3.66%
3M
+4.92%
6M
+21.60%
YTD
+5.75%
1Y
-4.93%
3Y
+61.94%
5Y
+117.68%
Price Chart
ETF Exposure
VRTX is held by 370 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| CFO | VictoryShares US 500 Enhanced Volatility Wtd ETF | 0.20% |
| GUSA | Goldman Sachs MarketBeta US 1000 Equity ETF | 0.20% |
| IYY | iShares Dow Jones U.S. ETF | 0.20% |
| ADME | Aptus Drawdown Managed Equity ETF | 0.20% |
| DFUS | Dimensional - US Equity Market ETF | 0.20% |
| SCHK | Schwab 1000 Index ETF | 0.20% |
| VOO | Vanguard S&P 500 ETF | 0.20% |
| XSPI | NEOS Boosted S&P 500 High Income ETF | 0.20% |
| EUSA | iShares MSCI USA Equal Weighted ETF | 0.20% |
| XSP.TO | iShares Core S&P 500 Index ETF (CAD- Hedged) | 0.20% |
| ENHU | iShares Enhanced Large Cap Core Active ETF | 0.20% |
| ACIO | Aptus Collared Income Opportunity ETF | 0.20% |
| AVLC | Avantis U.S. Large Cap Equity ETF | 0.20% |
| IWV | iShares Russell 3000 ETF | 0.20% |
| XRMI | Global X - S&P 500 Risk Managed Income ETF | 0.20% |
| XTR | Global X - S&P 500 Tail Risk ETF | 0.20% |
| SCHB | Schwab U.S. Broad Market ETF | 0.19% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.19% |
| SCHX | Schwab U.S. Large-Cap ETF | 0.19% |
| VONE | Vanguard Russell 1000 ETF | 0.19% |
| XOUT | GraniteShares XOUT U.S. Large Cap ETF | 0.19% |
| PTLC | Pacer Trendpilot US Large Cap ETF | 0.19% |
| FEX | First Trust Large Cap Core AlphaDEX Fund | 0.19% |
| ISPY | ProShares - S&P 500 High Income ETF | 0.19% |
| SPYH | NEOS S&P 500 Hedged Equity Income ETF | 0.19% |
| SPLG | SPDR Portfolio S&P 500 ETF | 0.18% |
| VTHR | Vanguard Russell 3000 ETF | 0.18% |
| XCHG | Alliance Bernstein - AB US Equity ETF | 0.18% |
| NTSX | WisdomTree U.S. Efficient Core Fund | 0.18% |
| VTI | Vanguard Total Stock Market ETF | 0.18% |
| FB | ProShares - S&P 500 Dynamic Buffer ETF | 0.18% |
| TACU | T. Rowe Price Active Core U.S. Equity ETF | 0.17% |
| OALC | OneAscent Large Cap Core ETF | 0.17% |
| HSPX | Global X S&P 500 Covered Call ETF | 0.17% |
| KLMT | Invesco MSCI Global Climate 500 ETF | 0.17% |
| EPS | WisdomTree U.S. LargeCap Fund | 0.17% |
| RSPA | Invesco S&P 500 Equal Weight Income Advantage ETF | 0.17% |
| URSP | ProShares - Ultra S&P 500 Equal Weight | 0.17% |
| TOK | iShares MSCI Kokusai ETF | 0.17% |
| KOKU | Xtrackers MSCI Kokusai Equity ETF | 0.16% |
| BBB | Cyber Hornet S&P 500 and Bitcoin 75/25 Strategy ETF | 0.16% |
| ILCG | iShares Morningstar Growth ETF | 0.15% |
| JKE | iShares Morningstar Growth ETF | 0.15% |
| URTH | iShares MSCI World ETF | 0.15% |
| QDPL | Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF | 0.15% |
| SSO | ProShares - Ultra S&P500 | 0.15% |
| MFUS | PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF | 0.15% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.15% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.14% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.14% |
About VRTX ETF Exposure
Vertex Pharmaceuticals Incorporated (VRTX) is held by 370 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 121.8B, VRTX is a widely held institutional stock. The stock currently trades at $479.41. Investors can gain exposure to VRTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VRTX, sorted by portfolio weight.